Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis-Reference-Cited by-同舟云学术

Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis

Published:2010-10-19 Issue:2 Volume:268 Page:165-179
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Rudolph Elisabeth,Dyckhoff Gerhard,Becher Heiko,Dietz Andreas,Ramroth Heribert

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s00405-010-1395-8.pdf

Reference72 articles.

1. Ferlay J, Bray F, Pisani P, Parkin D (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC cancer base no. 5, IARC, Lyon, version 1.0

2. Ramroth H, Dietz A, Becher H (2004) Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case–control study from Germany. Methods Inf Med 43:499–504. doi: 10.1267/METH04050499

3. Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T et al (2006) Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 164:367–375. doi: 10.1093/aje/kwj208

4. Talamini R, Bosetti C, Vecchia CL, Maso LD, Levi F, Bidoli E et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control 13:957–964

5. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D et al (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820. doi: 10.1093/aje/kwk066

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the Neck: An NCDB Study of Clinically Node‐Negative Supraglottic Squamous Cell Carcinoma;Otolaryngology–Head and Neck Surgery;2024-08-05

2. LncRNA FTH1P3: A new biomarker for cancer-related therapeutic development;Current Molecular Medicine;2023-07-24

3. The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma;Scientific Reports;2023-06-15

4. Construction of a novel MPT-driven necrosis-related lncRNAs signature for prognosis prediction in laryngeal squamous cell carcinoma;Environmental Science and Pollution Research;2023-05-30

5. LONG NON-CODING RNA LINC00958 AND microRNA MIR-627-5P PROVIDE CANDIDATE DIAGNOSTIC BIOMARKER AND PARTICIPATE TUMOR PROGRESSION IN LARYNGEAL SQUAMOUS CELL CARCINOMA: A RETROSPECTIVE STUDY;J PHYSIOL PHARMACOL;2023